Skip to main content
Log in

Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndrome

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Superoxide anion (O2 ) production and expression of cytochrome b558 by neutrophils were determined in 20 patients with myelodysplastic syndrome (MDS). The reduction of O2 production was noted in eight of the 20 patients and an increase was noted in four patients when neutrophils were stimulated byn-formylmethionyl-leucyl-phenylalanine (FMLP), while a low level of O2 production was found in 11 and an increase in six MDS patients when they were stimulated by phorbol myristate acetate (PMA). Among them, seven patients showed a decrease and four an increase in O2 production on stimulation with either FMLP or PMA. Expression of cytochrome b 558 was found to be at low levels in patients who had neutrophils showing decreased O2 production when stimulated with FMLP, indicating that decreased expression of cytochrome b558 might contribute to the impairment of O2 production in some MDS patients. In this study, no significant differences in O2 production were noted among subtypes of MDS; however, the patients who had received prednisolone showed lower levels of O2 production than those who had not received prednisolone. Patients manifesting episodes of infection had reduced levels of O2 production compared with those without infection. Furthermore, the fact that one patient who exhibited a marked reduction in neutrophil counts together with reduced O2 production died of fatal infection, suggests that the determination of O2 production, in combination with hematological features, may be of some help in predicting severe infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199

    PubMed  Google Scholar 

  2. Boogerts MA, Nelissen V, Roelant C, Goosens W (1983) Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol 55: 217–227

    PubMed  Google Scholar 

  3. Cech P, Markert M, Perrin LH (1983) Partial myeloperoxidase deficiency in preleukemia. Blut 47: 21–30

    PubMed  Google Scholar 

  4. Cross RA, Jones OT, Harper AM, Segal AW (1981) Oxidationreduction properties of the cytochrome b found in the plasmamembrane fraction of human neutrophils. A possible oxidase in the respiratory burst. Biochem J 194: 599–606

    PubMed  Google Scholar 

  5. Gahmberg CG, Andersson LC, Ruutu P, Timonen TT, Hänninen A, Vuopio P, de la Chapelle A (1979) Decrease of the major high-molecular-weight surface glycoprotein of human granulocytes in monosomy-7 associated with defective chemotaxis. Blood 54: 401–406

    PubMed  Google Scholar 

  6. Goldstein IM, Roos D, Weissmann G (1976) Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and Superoxide production. Inflammation 1: 305–315

    Google Scholar 

  7. Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 38: 1201–1217

    PubMed  Google Scholar 

  8. Klebanoff SJ, Clark RA (1978) The neutrophil: function and clinical disorders. North Holland, Amsterdam

    Google Scholar 

  9. Lehmeyer JE, Johnston RB (1978) Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol 9: 482–490

    PubMed  Google Scholar 

  10. Martin S, Baldock SC, Ghoneim AT, Child JA (1983) Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol 36: 1120–1128

    PubMed  Google Scholar 

  11. Metcalf JA, Gallin JI, Nauseef WM, Root RK (1986) Laboratory manual of neutrophil function. Raven, New York, pp 2–7

    Google Scholar 

  12. Nelson DH, Ruhmann-Wennhold A (1978) Inhibition of leukocyte Superoxide anion production by cortisol administration to normal subjects. J Clin Endocrinol Metab 46: 702–705

    PubMed  Google Scholar 

  13. Ojima T, Kuratsuji T, Shimizu S, Lee JY, Takahashi E, Takagi K (1984) Defective granulocyte function and chromosome abnormalities in hemopoietic dysplasia (in Japanese). Rinsho Ketsueki 25: 1204–1208

    PubMed  Google Scholar 

  14. Ruutu P, Ruutu T, Vuopio P, Kosunen TU, de la Chapelle A (1977) Defective chemotaxis in monosomy-7. Nature 265: 146–147

    PubMed  Google Scholar 

  15. Ruutu P, Ruutu T, Vuopio P, Kosunen TU, de la Chapelle A (1977) Function of neutrophils in preleukemia. Scand J Haematol 18: 317–325

    PubMed  Google Scholar 

  16. Schreiner A, Sohlberg CO (1976) Neutrophil dysfunction and granulomatosis in the preleukemic state. Scand J Infect Dis 8: 53–55

    PubMed  Google Scholar 

  17. Segal AW (1987) Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326: 88–91

    PubMed  Google Scholar 

  18. Segal AW, Jones OT (1978) Novel cytochrome b system in phagocytic vacuoles from human granulocytes. Nature 276: 515–517

    PubMed  Google Scholar 

  19. Segal AW, Jones OT, Webster D, Allison AC (1978) Absence of newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet 2: 446–449

    PubMed  Google Scholar 

  20. Shinagawa Y, Tanaka C, Taraoka A, Shinagawa Y (1966) A new cytochrome in neutrophilic granules of rabbit leucocyte. J Biochem 59: 622–624

    PubMed  Google Scholar 

  21. Takahashi I, Inagaki N, Nakada H, Ohmoto E, Takeuchi M, Osada K, Matsuzaki T, Fukuda S, Uchida K, Kohi F, Yorimitsu S, Kimura I, Kitajima K, Sanada H (1988) Superoxide anion production by neutrophils in myelodysplastic syndromes (preleukemia). Acta Med Okayama 42: 15–19

    PubMed  Google Scholar 

  22. Uike N, Hashimoto M, Takeichi N, Kozuru M (1989) Impaired Superoxide production by neutrophils in myelodysplastic syndrome: correlation with bone marrow karyotype (in Japanese). Rinsho Ketsueki 30: 830–834

    PubMed  Google Scholar 

  23. Yuo A, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Itoh S, Takaku F (1987) Recombinant human granulocyte colonystimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 70: 404–411

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itoh, Y., Kuratsuji, T., Aizawa, S. et al. Superoxide anion production and expression of cytochrome b 558 by neutrophils are impaired in some patients with myelodysplastic syndrome. Ann Hematol 63, 270–275 (1991). https://doi.org/10.1007/BF01698377

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01698377

Key words

Navigation